1. Astragaloside IV protects against C/EBP homologous protein-mediated apoptosis in oxidized low-density lipoprotein-treated macrophages by promoting autophagy
    Hua Tian et al, 2022, European Journal of Pharmacology CrossRef
  2. Astragaloside IV attenuates IL-1β-induced intervertebral disc degeneration through inhibition of the NF-κB pathway
    Yueyang Tian et al, 2022, Journal of Orthopaedic Surgery and Research CrossRef
  3. New insights into the interplay between autophagy and cartilage degeneration in osteoarthritis
    Xiaoman Lv et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
  4. Astragaloside inhibits IL-1β-induced inflammatory response in human osteoarthritis chondrocytes and ameliorates the progression of osteoarthritis in mice
    Hongtao Li et al, 2019, Immunopharmacology and Immunotoxicology CrossRef
  5. miRNA‑27a regulates arthritis via PPARγ in�vivo and in�vitro
    Yu Xiao et al, 2018, Molecular Medicine Reports CrossRef
  6. Autophagy in Osteoarthritis: A Double-Edged Sword in Cartilage Aging and Mechanical Stress Response: A Systematic Review
    Dong-Yeong Lee et al, 2024, Journal of Clinical Medicine CrossRef
  7. Association of astragaloside IV-inhibited autophagy and mineralization in vascular smooth muscle cells with lncRNA H19 and DUSP5-mediated ERK signaling
    Zhenhua Song et al, 2019, Toxicology and Applied Pharmacology CrossRef
  8. The Role of Astragaloside IV against Cerebral Ischemia/Reperfusion Injury: Suppression of Apoptosis via Promotion of P62-LC3-Autophagy
    Yi Zhang et al, 2019, Molecules CrossRef
  9. Autophagy: An important target for natural products in the treatment of bone metabolic diseases
    Zhichao Li et al, 2022, Frontiers in Pharmacology CrossRef
  10. Natural anti‐inflammatory products for osteoarthritis: From molecular mechanism to drug delivery systems and clinical trials
    Jianbang Su et al, 2023, Phytotherapy Research CrossRef
  11. Natural compounds against cytotoxic drug‐induced cardiotoxicity: A review on the involvement of PI3K/Akt signaling pathway
    Fatemeh Yarmohammadi et al, 2021, Journal of Biochemical and Molecular Toxicology CrossRef
  12. Role of Autophagy Mediated by AMPK/DDiT4/mTOR Axis in HT22 Cells Under Oxygen and Glucose Deprivation/Reoxygenation
    Yi Zhang et al, 2023, ACS Omega CrossRef
  13. Recent advance in treatment of osteoarthritis by bioactive components from herbal medicine
    Xu-zhao Li et al, 2020, Chinese Medicine CrossRef
  14. Astragaloside IV inhibits glucose-induced epithelial-mesenchymal transition of podocytes through autophagy enhancement via the SIRT–NF-κB p65 axis
    Xiaolei Wang et al, 2019, Scientific Reports CrossRef
  15. Tiao-bu-fei-shen formula promotes downregulation of the caveolin 1-p38 mapk signaling pathway in COPD - Associated tracheobronchomalacia cell model
    Pengcheng Zhou et al, 2022, Journal of Ethnopharmacology CrossRef
  16. Research Progress on the Antiosteoarthritic Mechanism of Action of Natural Products
    Mingzhu Gao et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
  17. Chemical diversity and biological activities of the saponins isolated from Astragalus genus: focus on Astragaloside IV
    Vittoria Graziani et al, 2019, Phytochemistry Reviews CrossRef
  18. Phytochemicals Mediate Autophagy Against Osteoarthritis by Maintaining Cartilage Homeostasis
    Zheng Tian et al, 2021, Frontiers in Pharmacology CrossRef
  19. Jianpiyifei II Granules Suppress Apoptosis of Bronchial Epithelial Cells in Chronic Obstructive Pulmonary Disease via Inhibition of the Reactive Oxygen Species-Endoplasmic Reticulum Stress-Ca2+ Signaling Pathway
    Long Fan et al, 2020, Frontiers in Pharmacology CrossRef
  20. Review of the pharmacological effects of astragaloside IV and its autophagic mechanism in association with inflammation
    Ying Yang et al, 2022, World Journal of Clinical Cases CrossRef
  21. Pharmacologic Interventions for Preventing Chondrocyte Apoptosis in Rheumatoid Arthritis and Osteoarthritis
    Charles J. Malemud, 2018, Drug Discovery - Concepts to Market CrossRef
  22. Astragaloside IV protects ATDC5 cells from lipopolysaccharide-caused damage through regulating miR-203/MyD88
    Dexin Li et al, 2020, Pharmaceutical Biology CrossRef
  23. Astragaloside IV Ameliorates Myocardial Infarction Induced Apoptosis and Restores Cardiac Function
    Chuang Sun et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  24. Cycloastragenol as an Exogenous Enhancer of Chondrogenic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells. A Morphological Study
    Marta Anna Szychlinska et al, 2020, Cells CrossRef
  25. Astragaloside IV protects against cisplatin-induced liver and kidney injury via autophagy-mediated inhibition of NLRP3 in rats
    Xiaoyu Qu et al, 2019, The Journal of Toxicological Sciences CrossRef